Course Overview
The USC graduate program in Health Economics offers a Master of Science in Pharmaceutical Economics and Policy. This MS program is offered jointly with the Department of Economics and the USC Price School of Public Policy . Master's students are trained to use pharmacoeconomics and assessment techniques in practical decision-making environments such as managed-care pharmacies, third-party payers and government agencies. A distinguishing characteristic of the USC Master's Program in Pharmaceutical Economics and Policy is the degree to which students are actively engaged in publishable research, either as the lead author or as a secondary author in collaboration with a faculty member. Employers now expect increased sophistication beyond the traditional disciplinary boundaries of PhD programs. Academia is looking for translational scientists who can build interdisciplinary teams to produce cutting-edge research that rapidly translates to innovative new therapies that impact patient care outcomes, publish in high profile journals and successfully compete for funding as well as train outstanding graduate students and post-doctoral researchers. This translational focus increasingly has shifted from in vitro to in vivo (preclinical) , drug optimization and clinical investigations, and requires an increased understanding of intellectual property and regulatory processes as well as impact on health economics and policy.
Study in Australia
Study in Canada
Study in Germany
Study in United Kingdom
Study in USA
Study in Switzerland